WAVE LIFE SCIENCES LTD. Investment Income, Dividend
WAVE LIFE SCIENCES LTD. (WVE) reported Investment Income, Dividend of $584.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-04.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeDividend · last filed 2021-03-04
- WAVE LIFE SCIENCES LTD. investment income, dividend for the quarter ending 2020-12-31 was $24.00K, a 96.74% decline year-over-year.
- WAVE LIFE SCIENCES LTD. investment income, dividend for the quarter ending 2020-09-30 was $40.00K, a 96.69% decline year-over-year.
- WAVE LIFE SCIENCES LTD. investment income, dividend for the quarter ending 2020-06-30 was $135.00K, a 91.26% decline year-over-year.
- WAVE LIFE SCIENCES LTD. investment income, dividend for the quarter ending 2020-03-31 was $385.00K, a 72.96% decline year-over-year.
- WAVE LIFE SCIENCES LTD. investment income, dividend for fiscal 2020 was $584.00K, a 88.11% decline from fiscal 2019.
- WAVE LIFE SCIENCES LTD. investment income, dividend for fiscal 2019 was $4.91M, a 45.84% increase from fiscal 2018.
- WAVE LIFE SCIENCES LTD. investment income, dividend for fiscal 2018 was $3.37M, a 113.43% increase from fiscal 2017.
- WAVE LIFE SCIENCES LTD. investment income, dividend for fiscal 2017 was $1.58M, a 518.82% increase from fiscal 2016.
| Period end | Investment Income, Dividend 3 month | Investment Income, Dividend 6 month | Investment Income, Dividend 9 month | Investment Income, Dividend 12 month |
|---|---|---|---|---|
| 2020-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $64.00K derived: sum of 2 quarters · filed 2021-03-04 | $199.00K derived: sum of 3 quarters · filed 2021-03-04 | $584.00K 10-K · filed 2021-03-04 |
| 2020-09-30 | $40.00K 10-Q · filed 2020-11-09 | $175.00K derived: sum of 2 quarters · filed 2020-11-09 | $560.00K 10-Q · filed 2020-11-09 | $1.30M derived: sum of 4 quarters · filed 2021-03-04 |
| 2020-06-30 | $135.00K 10-Q · filed 2020-08-10 | $520.00K 10-Q · filed 2020-08-10 | $1.26M derived: sum of 3 quarters · filed 2021-03-04 | $2.46M derived: sum of 4 quarters · filed 2021-03-04 |
| 2020-03-31 | $385.00K 10-Q · filed 2020-05-11 | $1.12M derived: sum of 2 quarters · filed 2021-03-04 | $2.33M derived: sum of 3 quarters · filed 2021-03-04 | $3.87M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-12-31 | $736.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $1.94M derived: sum of 2 quarters · filed 2021-03-04 | $3.49M derived: sum of 3 quarters · filed 2021-03-04 | $4.91M 10-K · filed 2021-03-04 |
| 2019-09-30 | $1.21M 10-Q · filed 2020-11-09 | $2.75M derived: sum of 2 quarters · filed 2020-11-09 | $4.18M 10-Q · filed 2020-11-09 | $5.19M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $1.54M 10-Q · filed 2020-08-10 | $2.97M 10-Q · filed 2020-08-10 | $3.98M derived: sum of 3 quarters · filed 2020-08-10 | $5.05M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $1.42M 10-Q · filed 2020-05-11 | $2.44M derived: sum of 2 quarters · filed 2020-05-11 | $3.50M derived: sum of 3 quarters · filed 2020-05-11 | $4.44M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $2.08M derived: sum of 2 quarters · filed 2020-03-02 | $3.01M derived: sum of 3 quarters · filed 2020-03-02 | $3.37M 10-K · filed 2020-03-02 |
| 2018-09-30 | $1.06M 10-Q · filed 2019-11-05 | $2.00M derived: sum of 2 quarters · filed 2019-11-05 | $2.35M 10-Q · filed 2019-11-05 | $2.65M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $934.00K 10-Q · filed 2019-08-06 | $1.29M 10-Q · filed 2019-08-06 | $1.58M derived: sum of 3 quarters · filed 2020-03-02 | $2.10M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $356.00K 10-Q · filed 2019-05-10 | $647.00K derived: sum of 2 quarters · filed 2020-03-02 | $1.16M derived: sum of 3 quarters · filed 2020-03-02 | $1.64M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $291.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $806.00K derived: sum of 2 quarters · filed 2020-03-02 | $1.29M derived: sum of 3 quarters · filed 2020-03-02 | $1.58M 10-K · filed 2020-03-02 |
| 2017-09-30 | $515.00K 10-Q · filed 2018-11-09 | $997.00K derived: sum of 2 quarters · filed 2018-11-09 | $1.29M 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $482.00K 10-Q · filed 2018-08-09 | $772.00K 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $290.00K 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $255.00K 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |